Lymphotoxin-α (TNF-β) during sepsis

Cytokine

Volumn 8, Issue 12, 1996, Pages 933-937

  Sriskandan, Shiranee ^a   Moyes, David ^a   Lemm, George ^b   Cohen, Jonathan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BAYER CORPORATION   (United States)

Author keywords

Lymphotoxin ; Sepsis syndrome; Septic shock; Tumour necrosis factor

Indexed keywords

EXOTOXIN; LYMPHOTOXIN; PYROGEN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; SEPSIS; T LYMPHOCYTE;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 0030513698     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0125     Document Type: Article

References (30)

1. 1. Andersson J, Nagy S, Bjork L, Abrams J, Holm S, Andersson U (1992) Bacterial toxin-induced cytokine production studied at the single cell level. Immunol Rev 127:69-96.
2. 2. Hackett SP, Stevens DL (1993) Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β synthesis. J Infect Dis 168:232-235.
3. 3. Sriskandan S, Evans TJ, Cohen J (1996) Bacterial superantigen-induced human lymphocyte responses are nitric oxide-dependent and mediated by IL-12 and IFN-gamma. J Immunol 156:2430-2435.
4. 4. Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316.
5. 5. Cosman D (1994) A family of ligands for the TNF receptor superfamily. Stem Cells 12:440-455.
6. 6. Paul NL, Ruddle NH (1988) Lymphotoxin. Annu Rev Immunol 6:407-438.
7. 7. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452.
8. 8. Chaturvedi MM, LaPushin R, Aggarwal BB (1994) Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response. J Biol Chem 269:14575-14583.
9. 9. English BK, Weaver WM, Wilson CB (1991) Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes. J Biol Chem 266:7108-7113.
10. 10. Broudy VC, Harlan JM, Adamson JW (1987) Disparate effects of tumor-necrosis factor-α/cachectin and tumor necrosis factor-β/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells. J Immunol 138:4298-4302.
11. 11. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF (1993) Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-856.
12. 12. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hessian C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (1994) A lymphotoxin-β-specific receptor. Science 264:707-709.
13. 13. Beutler B, van Huffel C (1994) Unraveling function in the TNF ligand and receptor families. Science 264:667-668.
14. 14. Strieter RM, Kunkel SL, Bone RC (1993) Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 21:S447-S463.
15. 15. Bone RC (1992) Towards an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455.
16. 16. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier J-C, Offenstadt G, Regnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. JAMA 274:968-974.
17. 17. Schlievert PM, Gocke JE, Deringer JR (1993) Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin Infect Dis 17:26-31.
18. 18. Matsushita K, Fujimaki W, Kato H, Uchiyama T, Igarashi H, Ohkuni H, Nagaoka S, Kawagoe M, Kotani S, Takada H (1995) Immunopathological activities of extracellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect Immun 63:785-793.
19. 19. Kotb M (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8:411-426.
20. 20. Fleischer B, Gerlach D, Fuhrmann A, Schmidt K-H (1995) Superantigens and pseudosuperantigens of Gram positive cocci. Med Microbiol Immunol 184:1-8.
21. 21. Keuter M, Dharmana E, Gasem MH, van der Ven-Jongekrijg J, Djokomoeljanto R, Dolmans WMV, Demacker P, Sauerwein R, Gallati H, van der Meer JWM (1994) Patterns of pro-inflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 169:1306-1311.
22. 22. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML (1995) Lymphotoxin-α-deficient mice. J Immunol 155:1685-1693.
23. 23. Clark IA, Gray KM, Rockett EJ, Cowden WB, Rockett KA, Ferrante A, Aggarwal BB (1992) Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology. Trans R Soc Trop Med Hyg 86:602-607.
24. 24. Ishibashi K, Ishitsuka K, Chuman Y, Otsuka M, Kuwazuru Y, Iwahashi M, Utsunomiya A, Kanada S, Sakurami T, Arima T (1991) Tumor necrosis factor-β in the serum of adult T-cell leukemia with hypercalcemia. Blood 77:2451-2455.
25. 25. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, Murray JF (1990) Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141:94-97.
26. 26. van der Linden CJ, Engelberts I, Buurman WA (1992) Tumor necrosis factor during sepsis. In Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine, Springer Verlag, Berlin, pp 44-48.
27. 27. Shapiro L, Clark BD, Orencole SF, Potsiaka DD, Granowitz EV, Dinarello (1993) Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis 167:1344-1350.
28. 28. Browning JL, Dougas I, Ngam-ek A, Bourdon PR, Ehrenfels BN, Miatkowski K, Zafari M, Yampaglia AM, Lawton P, Meier W, Benjamin CP, Hession C (1995) Characterization of surface lymphotoxin forms. J Immunol 154:33-46.
29. 29. Cohen J, Carlet J, for the Intersept study group. (1996) Intersept: an international multicenter placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis. Crit Care Med: 24:1431-1440.
30. 30. Altman DG (1991) Practical Statistics for Medical Research. In Practical Statistics for Medical Research. London: Chapman & Hall, 179-395.